TITANIUM PLATFORM

Sample Program

Hand-carry, direct-to-practitioner, direct-to-representative, hybrid, remote sampling and more

Distribution Management

Full-service and nationally available warehousing, fulfillment, distribution, and logistics services

Compliance Program

Spend transparency, practitioner license validation, representative licensing, and distribution licensing.

KOL & Targeting

Key opinion leader identification, sentiment analysis, and dynamically generated HCP targets

Digital Solutions

Hosted web portals, e-signature capture, and alternative e-commerce digital channel capabilities

Learning Programs

Online & asynchronous enterprise training

Home > Regulatory Alerts > May 26, 2026 – State of Massachusetts Regulatory Alert

As required under the Massachusetts Pharmaceutical and Medical Device Code of Conduct Regulation (105 CMR 970.000), manufacturers must report certain payments and comply with annual registration requirements by July 1st of each year. Full regulatory details are available here: 105 CMR 970.000

Manufacturers must disclose any fee, payment, subsidy, or other economic benefit valued at $50 or more provided to a Massachusetts Covered Recipient, unless the payment is already disclosed under federal reporting (e.g., Open Payments/Transparency reporting), in which case it is exempt from separate Massachusetts disclosure.


Important: The definition of a Covered Recipient under Massachusetts law differs from the federal definition and may include additional recipient types (e.g., certain healthcare practitioners such as PharmDs, and RNs). For more information, click here: MA Pharmaceutical Code of Conduct Requirements

 

Even if no reportable transactions occurred, manufacturers must still complete the following:

  1. Annual Registration Renewal
  2. Payment of the $2,000 Annual Fee
  3. Submission of a Disclosure Report or a Zero-Spend Disclosure

 

To submit a zero-spend disclosure, you must officially report via email. There is no special form or portal submission available. 

 “[Company Name] is a registered pharmaceutical/medical device manufacturer in Massachusetts.

For calendar year 2025, the company had no reportable payments or other economic benefits to covered recipients.

This email serves as our disclosure submission for the reporting year.”

 

May 26, 2026 State of Massachusetts Regulatory Alert

All renewals and payments must be completed online prior to July 1, 2026:

Chatbot Icon
TITANIUM PLATFORM

Sample Management

Hand-carry, direct-to-practitioner, direct-to-representative, hybrid, remote sampling and more

Distribution Management

Full-service and nationally available warehousing, fulfillment, distribution, distribution licensing, and logistics services

Compliance Program

Spend transparency, practitioner license validation, and representative licensing

KOL & HCP Targeting

Key opinion leader identification, sentiment analysis, and dynamically generated HCP targets

Digital Solutions

Hosted web portals, e-signature capture, and alternative e-commerce digital channel capabilities

Training Solutions

Online & continuing education enterprise training

INDUSTRIES SERVED